Regeneron Predicts Impending Biosimilar Lucentis Impact On Eylea Brand

Samsung Bioepis Tipped For US Ranibizumab Biosimilar Approval Soon

 
• By Dean Rudge
Eye
Biosimilar ranibizumab is due to launch in the US later this year • Source: Shutterstock

More from Biosimilars

More from Products